Harvett,
Once again you have (deliberately?) distorted the truth.
You state that "Even a placebo with carboplatin added at AUC2 proceduced (sic) a median PFS of 20 weeks. And we are suppose to applaud for 12 weeks." What you failed to say was that carboplatin at AUC=2 in this case was administered WEEKLY.
This was equivalent to AUC=8 monthly, twice the dose used with NOX66. I'm sure you will respond with some irrelevant data that suits your purpose, but I do not care.
The great pity is that your vendetta has no doubt turned some investors off Noxopharm and thus deprived them of a windfall gain. Well done.
ESMO Presentation, page-19
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $8.304K | 80.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 124999 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
